Page last updated: 2024-10-23

bisbenzimidazole and Trichomonas Vaginitis

bisbenzimidazole has been researched along with Trichomonas Vaginitis in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Trichomonas Vaginitis: Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korosh, T1
Bujans, E1
Morada, M1
Karaalioglu, C1
Vanden Eynde, JJ1
Mayence, A1
Huang, TL1
Yarlett, N1

Other Studies

1 other study available for bisbenzimidazole and Trichomonas Vaginitis

ArticleYear
Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates.
    Chemical biology & drug design, 2017, Volume: 90, Issue:4

    Topics: Animals; Antiprotozoal Agents; Bisbenzimidazole; Cell Line, Tumor; Drug Resistance; Female; Humans;

2017